News & Announcements
AGENA AND SIMCEREDX ANNOUNCE STRATEGIC PARTNERSHIP TO DEVELOP AND COMMERCIALIZE COMPANION DIAGNOSTICS IN CHINA
SAN DIEGO, Calif., and NANJING, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusing on expan [...]
Carterra™ Announces Multiple Sales of its New LSA™ Array SPR Instrument for Comprehensive Monoclonal Antibody Characterization
Salt Lake City, Utah, USA… Carterra Inc., an innovative label-free biosensor company, announced today that it has sold multiple units of its new, fully integrated, high throughput monoclonal antibody (mAb) screening and characterization instrument, t [...]
Carterra Inc. Raises $10M from Telegraph Hill Partners to Develop and Launch Next-Generation Antibody Characterization Platform
Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization Salt Lake City, Utah, USA…Carterra Inc., an innovative label-free biosensor company, has announced the cl [...]
Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer
AUSTIN, Texas-- Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology by bringing complex molecular tests to hospital and reference labs, today announced that it has expanded its [...]
AQUARO HISTOLOGY COMPLETES FINANCING TO SUPPORT COMMERCIALIZATION OF AUTOMATED MICROTOMY TECHNOLOGY
October 24, 2017 Ann Arbor, MI: Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC) announced today the completion of a Series A funding round of $9.8 million led by Telegraph Hill Partners. This investment will enable Aquaro Histology [...]
HIGHLY SENSITIVE ASSESSMENT OF COMMON SOMATIC MUTATIONS IN PULMONARY NON-SMALL CELL CARCINOMA WITH THE MASSARRAY® SYSTEM
San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based platform and new, highly sensitive iPLEX® HS chemistry for detection of somatic mutatio [...]